37 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... filtration rate; DOAC ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Hepatitis B Management in Cancer

DOI: 10.1200/JCO.20.01757

#HepatitisB #HBV #HepBV #Management #Cancer #oncology #hepatology #algorithm
Hepatitis B Management ... HepatitisB #HBV #HepBV #Management ... #Cancer #oncology ... #hepatology #algorithm
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... DOACs are substrates ... metabolization of DOACs ... #Chemotherapy #Oncology ... #Hematology #Interactions
Cholangiocarcinoma Management Algorithm

doi: 10.1038/s41575-020-0310-z

#Cholangiocarcinoma #Management #Algorithm #treatment #oncology #hepatology
Cholangiocarcinoma Management ... Cholangiocarcinoma #Management ... Algorithm #treatment #oncology ... #hepatology
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
Lymphadenopathy - Differential ... Lymphadenopathy #LAD #Differential ... Algorithm #Causes #Hematology ... #Oncology
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
lymphoma (DLBCL) - Management ... lymphoma #DLBCL #Management ... Treatment #Algorithm #oncology ... #hematology
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Hodgkins #Lymphoma #oncology ... #Hematology #management
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Treatment #Algorithm #management ... #hematology #oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Ascites - Differential Diagnosis
Chronic liver disease (cirrhosis or chronic hepatitis) - 80%
Underlying malignancy - 10%
Congestive heart
Ascites - Differential ... Diagnosis Chronic liver ... Cirrhosis and another etiology ... <1% #Ascites #Differential ... #Diagnosis #hepatology